US Stock MarketDetailed Quotes

CRISPR Therapeutics (CRSP)

Watchlist

54.830
+2.410+4.60%

Close May 8 16:00 ET

54.519
-0.311-0.57%

Post 20:01 ET

5.29BMarket Cap-8.89P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics (CRSP) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-101.86%-108.9M

-141.65%-345.01M

-84.99%-92.55M

20.84%-84.63M

-19.14%-113.88M

-149.15%-53.95M

45.17%-142.77M

47.92%-50.03M

-168.25%-106.91M

28.27%-95.58M

Net income from continuing operations

9.61%-122.93M

-58.80%-581.6M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136M

-138.43%-366.25M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

Depreciation and amortization

-8.80%4.32M

1.14%19.48M

16.91%5.66M

-6.46%4.43M

-4.05%4.65M

-2.01%4.74M

-2.91%19.26M

-1.18%4.84M

-3.78%4.74M

-2.34%4.85M

Other non cash items

290.59%8.8M

288.32%72.73M

45.14%-8.31M

-47.01%-10.14M

1,186.97%88.93M

126.87%2.25M

-174.96%-38.62M

-217.98%-15.16M

-33.69%-6.9M

-159.63%-8.18M

Change In working capital

-128.09%-15.41M

-54.00%71.88M

192.95%22.64M

127.03%10.91M

-257.41%-16.51M

-73.94%54.85M

180.72%156.27M

88.06%-24.35M

-176.78%-40.36M

113.27%10.49M

-Change in receivables

--0

-85.71%25M

--0

-87.50%25M

187.50%175M

87.50%-25M

--0

-Change in prepaid assets

61.04%-247K

-36.86%3.34M

2,088.64%3.85M

212.77%212K

-103.96%-93K

-121.50%-634K

-77.24%5.29M

-97.27%176K

-123.01%-188K

-39.98%2.35M

-Change in payables and accrued expense

-130.27%-13.02M

264.55%44.89M

156.32%4.42M

131.91%12.18M

-258.39%-14.7M

355.34%43M

-34.75%-27.28M

14.59%-7.85M

-54.53%-38.16M

180.17%9.28M

-Change in other current liabilities

98.11%-199K

-55.76%4.26M

35.74%13.55M

2,487.10%802K

1,007.50%443K

-2,340.05%-10.54M

8,649.09%9.62M

1,316.31%9.99M

128.18%31K

112.70%40K

-Change in other working capital

1.37%-1.95M

11.78%-5.61M

148.65%810K

-11.66%-2.28M

-83.38%-2.16M

-34.35%-1.98M

-290.70%-6.36M

14.09%-1.67M

-131.19%-2.04M

-7.18%-1.18M

Cash from discontinued investing activities

Operating cash flow

-101.86%-108.9M

-141.65%-345.01M

-84.99%-92.55M

20.84%-84.63M

-19.14%-113.88M

-149.15%-53.95M

45.17%-142.77M

47.92%-50.03M

-168.25%-106.91M

28.27%-95.58M

Investing cash flow

Cash flow from continuing investing activities

-1,979.19%-410.74M

88.66%-31.81M

-64.85%37.2M

26.22%-119.23M

155.14%69.98M

79.80%-19.76M

-174.87%-280.48M

229.93%105.83M

-233.17%-161.6M

-158.50%-126.91M

Net PPE purchase and sale

-144.66%-504K

51.92%-914K

-103.54%-517K

66.21%-74K

83.45%-117K

71.43%-206K

79.93%-1.9M

65.58%-254K

89.66%-219K

80.11%-707K

Net intangibles purchase and sale

----

---25M

--0

----

--0

----

Net investment purchase and sale

-1,998.52%-410.24M

97.89%-5.89M

-64.45%37.72M

26.17%-119.15M

175.35%95.09M

79.86%-19.55M

-172.06%-278.58M

231.43%106.08M

-229.66%-161.39M

-156.85%-126.2M

Cash from discontinued investing activities

Investing cash flow

-1,979.19%-410.74M

88.66%-31.81M

-64.85%37.2M

26.22%-119.23M

155.14%69.98M

79.80%-19.76M

-174.87%-280.48M

229.93%105.83M

-233.17%-161.6M

-158.50%-126.91M

Financing cash flow

Cash flow from continuing financing activities

5,490.37%591.91M

28.33%426.03M

589.82%116.41M

2,978.49%296.77M

584.55%2.26M

-96.54%10.59M

429.78%331.98M

-56.66%16.88M

519.54%9.64M

-102.78%-466K

Net common stock issuance

----

32.39%398.09M

645.31%111.49M

4,532.77%278.11M

97.83%-22K

-96.97%8.52M

818.97%300.7M

-54.28%14.96M

--6M

---1.01M

Net preferred stock issuance

--600M

----

--0

----

Proceeds from stock option exercised by employees

197.20%6.16M

-10.72%27.94M

156.81%4.92M

413.09%18.66M

317.58%2.28M

-91.77%2.07M

4.50%31.29M

-69.17%1.92M

133.74%3.64M

-96.74%546K

Net other financing activities

---14.25M

----

Cash from discontinued financing activities

Financing cash flow

5,490.37%591.91M

28.33%426.03M

589.82%116.41M

2,978.49%296.77M

584.55%2.26M

-96.54%10.59M

429.78%331.98M

-56.66%16.88M

519.54%9.64M

-102.78%-466K

Net cash flow

Beginning cash position

15.92%359.08M

-22.76%309.78M

25.64%298.02M

-58.64%205.14M

-65.69%246.7M

-22.76%309.78M

79.00%401.07M

-56.04%237.19M

8.63%495.99M

101.88%718.94M

Current changes in cash

214.50%72.27M

153.91%49.21M

-15.98%61.06M

135.89%92.91M

81.32%-41.65M

-119.85%-63.11M

-151.58%-91.27M

152.44%72.67M

-411.72%-258.88M

-321.97%-222.95M

Effect of exchange rate changes

-178.05%-32K

552.38%95K

101.15%1K

-136.00%-27K

3,900.00%80K

472.73%41K

-128.77%-21K

-242.62%-87K

256.25%75K

-92.86%2K

End cash Position

74.83%431.31M

15.92%359.08M

25.64%298.02M

-58.64%205.14M

-65.69%246.7M

-22.76%309.78M

-56.04%237.19M

8.63%495.99M

Free cash flow

-102.02%-109.4M

-156.39%-370.93M

-85.09%-93.07M

20.93%-84.71M

-44.35%-139M

-149.67%-54.15M

46.88%-144.68M

48.06%-50.29M

-149.29%-107.13M

30.38%-96.29M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-101.86%-108.9M	-141.65%-345.01M	-84.99%-92.55M	20.84%-84.63M	-19.14%-113.88M	-149.15%-53.95M	45.17%-142.77M	47.92%-50.03M	-168.25%-106.91M	28.27%-95.58M
Net income from continuing operations	9.61%-122.93M	-58.80%-581.6M	-250.07%-130.61M	-23.85%-106.44M	-64.98%-208.55M	-16.64%-136M	-138.43%-366.25M	-141.76%-37.31M	23.37%-85.94M	-62.60%-126.41M
Depreciation and amortization	-8.80%4.32M	1.14%19.48M	16.91%5.66M	-6.46%4.43M	-4.05%4.65M	-2.01%4.74M	-2.91%19.26M	-1.18%4.84M	-3.78%4.74M	-2.34%4.85M
Other non cash items	290.59%8.8M	288.32%72.73M	45.14%-8.31M	-47.01%-10.14M	1,186.97%88.93M	126.87%2.25M	-174.96%-38.62M	-217.98%-15.16M	-33.69%-6.9M	-159.63%-8.18M
Change In working capital	-128.09%-15.41M	-54.00%71.88M	192.95%22.64M	127.03%10.91M	-257.41%-16.51M	-73.94%54.85M	180.72%156.27M	88.06%-24.35M	-176.78%-40.36M	113.27%10.49M
-Change in receivables	--0	-85.71%25M	--0	--0	--0	-87.50%25M	187.50%175M	87.50%-25M	--0	--0
-Change in prepaid assets	61.04%-247K	-36.86%3.34M	2,088.64%3.85M	212.77%212K	-103.96%-93K	-121.50%-634K	-77.24%5.29M	-97.27%176K	-123.01%-188K	-39.98%2.35M
-Change in payables and accrued expense	-130.27%-13.02M	264.55%44.89M	156.32%4.42M	131.91%12.18M	-258.39%-14.7M	355.34%43M	-34.75%-27.28M	14.59%-7.85M	-54.53%-38.16M	180.17%9.28M
-Change in other current liabilities	98.11%-199K	-55.76%4.26M	35.74%13.55M	2,487.10%802K	1,007.50%443K	-2,340.05%-10.54M	8,649.09%9.62M	1,316.31%9.99M	128.18%31K	112.70%40K
-Change in other working capital	1.37%-1.95M	11.78%-5.61M	148.65%810K	-11.66%-2.28M	-83.38%-2.16M	-34.35%-1.98M	-290.70%-6.36M	14.09%-1.67M	-131.19%-2.04M	-7.18%-1.18M
Cash from discontinued investing activities
Operating cash flow	-101.86%-108.9M	-141.65%-345.01M	-84.99%-92.55M	20.84%-84.63M	-19.14%-113.88M	-149.15%-53.95M	45.17%-142.77M	47.92%-50.03M	-168.25%-106.91M	28.27%-95.58M
Investing cash flow
Cash flow from continuing investing activities	-1,979.19%-410.74M	88.66%-31.81M	-64.85%37.2M	26.22%-119.23M	155.14%69.98M	79.80%-19.76M	-174.87%-280.48M	229.93%105.83M	-233.17%-161.6M	-158.50%-126.91M
Net PPE purchase and sale	-144.66%-504K	51.92%-914K	-103.54%-517K	66.21%-74K	83.45%-117K	71.43%-206K	79.93%-1.9M	65.58%-254K	89.66%-219K	80.11%-707K
Net intangibles purchase and sale	----	---25M	--0	--0	----	----	--0	--0	--0	----
Net investment purchase and sale	-1,998.52%-410.24M	97.89%-5.89M	-64.45%37.72M	26.17%-119.15M	175.35%95.09M	79.86%-19.55M	-172.06%-278.58M	231.43%106.08M	-229.66%-161.39M	-156.85%-126.2M
Cash from discontinued investing activities
Investing cash flow	-1,979.19%-410.74M	88.66%-31.81M	-64.85%37.2M	26.22%-119.23M	155.14%69.98M	79.80%-19.76M	-174.87%-280.48M	229.93%105.83M	-233.17%-161.6M	-158.50%-126.91M
Financing cash flow
Cash flow from continuing financing activities	5,490.37%591.91M	28.33%426.03M	589.82%116.41M	2,978.49%296.77M	584.55%2.26M	-96.54%10.59M	429.78%331.98M	-56.66%16.88M	519.54%9.64M	-102.78%-466K
Net common stock issuance	----	32.39%398.09M	645.31%111.49M	4,532.77%278.11M	97.83%-22K	-96.97%8.52M	818.97%300.7M	-54.28%14.96M	--6M	---1.01M
Net preferred stock issuance	--600M	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	197.20%6.16M	-10.72%27.94M	156.81%4.92M	413.09%18.66M	317.58%2.28M	-91.77%2.07M	4.50%31.29M	-69.17%1.92M	133.74%3.64M	-96.74%546K
Net other financing activities	---14.25M	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	5,490.37%591.91M	28.33%426.03M	589.82%116.41M	2,978.49%296.77M	584.55%2.26M	-96.54%10.59M	429.78%331.98M	-56.66%16.88M	519.54%9.64M	-102.78%-466K
Net cash flow
Beginning cash position	15.92%359.08M	-22.76%309.78M	25.64%298.02M	-58.64%205.14M	-65.69%246.7M	-22.76%309.78M	79.00%401.07M	-56.04%237.19M	8.63%495.99M	101.88%718.94M
Current changes in cash	214.50%72.27M	153.91%49.21M	-15.98%61.06M	135.89%92.91M	81.32%-41.65M	-119.85%-63.11M	-151.58%-91.27M	152.44%72.67M	-411.72%-258.88M	-321.97%-222.95M
Effect of exchange rate changes	-178.05%-32K	552.38%95K	101.15%1K	-136.00%-27K	3,900.00%80K	472.73%41K	-128.77%-21K	-242.62%-87K	256.25%75K	-92.86%2K
End cash Position	74.83%431.31M	15.92%359.08M	15.92%359.08M	25.64%298.02M	-58.64%205.14M	-65.69%246.7M	-22.76%309.78M	-22.76%309.78M	-56.04%237.19M	8.63%495.99M
Free cash flow	-102.02%-109.4M	-156.39%-370.93M	-85.09%-93.07M	20.93%-84.71M	-44.35%-139M	-149.67%-54.15M	46.88%-144.68M	48.06%-50.29M	-149.29%-107.13M	30.38%-96.29M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm